Tagged with R&D

R&D Tatiana Vidaurre is currently chief of Instituto Nacional de Enfermedades Neoplásicas (INEN), Peru’s sole institution dedicated to cancer. She talks about the importance of global collaboration and their ultimate goal of preventing advanced-stage cancer.   INEN’s history dates back to 1939, with a colorful history in Peru throughout the decades.…

immunology The executive director of the university spin-off UDIMEB explains the major achievements of the institution, her plans to convert it into a strategic partner to the pharmaceutical and biotechnology industry to conduct pre-clinical tests and the challenges spin-off initiatives face today in Mexico.     In the past pharmaceutical R&D activities…

Janssen Janssen’s managing director in Korea discusses the groups long and significant commitment to R&D in the country, as well as some of the challenges that one of the most innovative multinational companies must face in a market that has traditionally been reluctant to recognize the value of highly innovative products.…

R&D Gador’s first general director from outside of the family discusses his mission, Gador’s key to success, and his method for successfully leading a company in Argentina’s unpredictable and volatile market. What was the mission that you were given when you were made the general director? This is the first time…

clinical research The head of Management Center for the North West Africa of a large multinational speaks out about the defining characteristics of the Algerian pharmaceutical market and discusses the importance of training local medical practitioners in clinical research techniques and methodologies. Now, you are the Head of the Management Center for…

R&D Lee Kyoung-Ryul has served as Chairman of SCL Healthcare Group since 2007. He discusses the diagnostic service providers’ extensive network in Korea as well as their ambitious plans to export their systems to China. What has been the most important long-term goal for you since you started? The most important…

biotech On February second, the Korean Ministry of Health and Welfare announced the start of a second round of financing to the biopharmaceutical industry, as part of the Global Pharmaceutical Industry Development Fund (GPIDF). A total of USD 123 million will be invested in Korean pharmaceutical and biotech companies for the…

R&D The founder of Eriochem discusses his firm’s ambitious technology based on a competitive IP strategy and its exciting research on a radically new oncology platform. Today, Eriochem is a vertically integrated company producing both APIs and final dosage forms; when you started the company, what was the strategy you followed…

R&D Brian Wang, CEO of Korean super-generics developer GL PharmTech, discusses Korea’s relative strengths in different stages of R&D, and how this motivated the foundation and evolution of GL PharmTech. What was the inspiration that prompted you to found GL PharmTech, a company based on incrementally modified drugs, back in 2002?…

R&D James Jun, CEO of KT&G Life Sciences, discusses his company’s new entry into the Korean pharma market and the role that the KT&G brand can play in accelerating its drug development process. How did KT&G Life Sciences begin, and what was the reasoning behind starting this company in the first…

R&D The first woman appointed as general director of one of the leading neurosciences institutions in Latin America discusses the Institute’s priorities in terms of R&D for brain diseases, training of high-specialty medical professionals and the increasing trend towards “feminization of medicine” in Mexico. You were appointed general director of the…

manufacturing The country manager for Algeria discusses how the company was the first foreign entity to engage in local manufacturing and sheds light on some of the difficulties in introducing innovative molecules to the market. Pfizer was one of the first multinationals to engage with the Algerian pharmaceuticals market and enjoys…